MY148252A - 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines - Google Patents

6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines

Info

Publication number
MY148252A
MY148252A MYPI20041687A MYPI20041687A MY148252A MY 148252 A MY148252 A MY 148252A MY PI20041687 A MYPI20041687 A MY PI20041687A MY PI20041687 A MYPI20041687 A MY PI20041687A MY 148252 A MY148252 A MY 148252A
Authority
MY
Malaysia
Prior art keywords
alkylmethyl
cyclymethyl
substituted pyrazolopyrimidines
pyrazolopyrimidines
substituted
Prior art date
Application number
MYPI20041687A
Other languages
English (en)
Inventor
Martin Dr Hendrix
Lars Dr Barfacker
Christina Dr Erb
Frank-Thorsten Dr Hafner
Heike Dr Heckroth
Dagmar Schaus
Adrian Dr Tersteegen
Franz-Jozef Van Der Dr Staay
Marja Van Dr Kampen
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MY148252A publication Critical patent/MY148252A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
MYPI20041687A 2003-05-09 2004-05-07 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines MY148252A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10320784 2003-05-09
DE10336183 2003-08-07
DE102004004142A DE102004004142A1 (de) 2003-05-09 2004-01-28 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine

Publications (1)

Publication Number Publication Date
MY148252A true MY148252A (en) 2013-03-29

Family

ID=33420016

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20041687A MY148252A (en) 2003-05-09 2004-05-07 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines

Country Status (9)

Country Link
EP (1) EP2298773B1 (enrdf_load_stackoverflow)
JP (1) JP5277303B2 (enrdf_load_stackoverflow)
CL (1) CL2004000978A1 (enrdf_load_stackoverflow)
DE (1) DE102004004142A1 (enrdf_load_stackoverflow)
MY (1) MY148252A (enrdf_load_stackoverflow)
NZ (1) NZ543812A (enrdf_load_stackoverflow)
PE (1) PE20050201A1 (enrdf_load_stackoverflow)
RU (1) RU2383546C2 (enrdf_load_stackoverflow)
TW (1) TWI350836B (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201439091A (zh) * 2013-04-05 2014-10-16 Eisai R&D Man Co Ltd 吡啶基吡唑并喹啉化合物
CN110545812A (zh) 2017-06-01 2019-12-06 卫材R&D管理有限公司 包含pde9抑制剂的药物组合物
EP3632438B1 (en) 2017-06-01 2023-08-23 Eisai R&D Management Co., Ltd. Lewy body disease therapeutic agent containing pyrazoloquinoline derivative
ES2985184T3 (es) 2017-06-01 2024-11-04 Eisai R&D Man Co Ltd Agente terapéutico para la demencia que combina derivado de pirazoloquinolina y memantina
EP3632439B1 (en) 2017-06-01 2024-03-27 Eisai R&D Management Co., Ltd. Dementia therapeutic agent combining pyrazoloquinoline derivative and donepezil

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1147234B (de) 1960-05-11 1963-04-18 Ciba Geigy Verfahren zur Herstellung von 1-Isopropyl-4-hydroxy-6-benzyl-pyrazolo[3, 4-d]pyrimidin
CH396926A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
CH396927A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
DE1149013B (de) 1960-05-11 1963-05-22 Ciba Geigy Verfahren zur Herstellung von 4-Oxo-4, 5-dihydro-pyrazolo-[3, 4-d]Pyrimidinen
DE1161281B (de) 1960-05-11 1964-01-16 Ciba Aktiengesellschaft, Basel (Schweiz) Verfahren zur Herstellung von 1-Alkyl-6-aralkyl-pyrazoloÄ3,4-dÜ-pyrimidinen.
CH396925A (de) * 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
CH396924A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung von 4-Mercapto-pyrazolo(3,4-d)pyrimidinen
US3732225A (en) 1970-07-23 1973-05-08 Squibb & Sons Inc Pyrazolo(3,4-d)pyrimidine derivatives
US3847908A (en) 1973-03-05 1974-11-12 Squibb & Sons Inc 6-styrylpyrazolo(3,4-d)pyrimidinones and pyrimidines
DE59009485D1 (de) 1989-01-26 1995-09-14 Bayer Ag Optisch aktive (Meth)Acrylsäure-Derivate, ihre Herstellung, ihre Polymerisation zu optisch aktiven Polymeren und deren Verwendung.
RU2104216C1 (ru) * 1994-01-10 1998-02-10 Акционерное общество открытого типа "Таганрогский авиационный научно-технический комплекс им.Г.М.Бериева" Замок
DE19709877A1 (de) 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
JP2004505054A (ja) * 2000-08-01 2004-02-19 バイエル　アクチェンゲゼルシャフト 知覚を改善する医薬品としての選択的ｐｄｅ２インヒビター
WO2003037432A1 (en) * 2001-11-02 2003-05-08 Pfizer Products Inc. Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
HN2002000317A (es) * 2001-11-02 2003-05-21 Pfizer Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
DE10219435A1 (de) * 2002-05-02 2003-11-13 Bayer Cropscience Ag Substituierte Pyrazolo-pyrimidin-4-one

Also Published As

Publication number Publication date
TWI350836B (en) 2011-10-21
DE102004004142A1 (de) 2004-11-25
TW200508237A (en) 2005-03-01
EP2298773B1 (de) 2013-06-19
RU2383546C2 (ru) 2010-03-10
JP5277303B2 (ja) 2013-08-28
EP2298773A1 (de) 2011-03-23
JP2012036221A (ja) 2012-02-23
NZ543812A (en) 2010-06-25
RU2005138339A (ru) 2006-08-10
CL2004000978A1 (es) 2005-03-18
PE20050201A1 (es) 2005-05-27

Similar Documents

Publication Publication Date Title
WO2003055878A8 (de) 2-heteroarylcarbonsäureamide
WO2003078431A8 (de) Aza- bicyclische n-biarylamide mit affinität zum alpha7 nikotinischen acetylcholin-rezeptor
IL173204A0 (en) Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
AU2002341920A1 (en) Chemical compounds
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
TW200738270A (en) Method of treating depression using a TNFα antibody
TW200505875A (en) Novel compounds
WO2007000325A3 (de) Substituierte 1-oxa-3,8-diazaspiro[4.5]-decan-2-on-verbindungen und deren verwendung zur herstellung von arzneimitteln
PL1928836T3 (pl) Podstawione 4-fenylotetrahydroizochinoliny, sposób ich wytwarzania, zastosowanie jako lek oraz lek je zawierający
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
WO2004026286A3 (de) Selektive phosphodiesterase 9a-inhibitoren als arzneimittel zur verbesserung kognitiver prozesse
MXPA05008478A (es) Heterociclos sustituidos.
DE50305587D1 (en) 2-heteroarylcarbonsäureamide
MX2007002470A (es) Fenilaminotiazoles sustituidos y su uso.
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
WO2004043379A3 (en) Chemical compounds
TW200510449A (en) Acylated nonadepsipeptides
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
TW200510398A (en) Novel compounds
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
WO2005010165A3 (en) Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
AU2003262026A1 (en) Method of producing structural body that functions as seat, backrest, partition, etc., and structural body produced by the method
MY148252A (en) 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза